EMIT 2000 Mycophenolic Acid Assay*

MPA concentrations are highly variable in patients receiving the drug. As such, treatment needs to be individualized depending on transplant type, co-administrated drugs, time post transplant, and other factors. The EMIT® 2000 MPA assay is a simple, easy-to-use solution to help clinicians better manage MPA therapy in transplant patients.


Features

  • Results available within 10 minutes
  • Utilizes plasma samples - no pretreatment required
  • Assay can be performed alongside 3 other immunosuppressive drugs
  • Correlates to the HPLC reference method

 

Advantages

  • Streamlined ISD monitoring for enhanced productivity
  • Benefit from up to 4 different ISD methods on one single V-Twin® or Viva-E® drug testing system
     

 

EMIT 2000 MPA Assay

Product Code

6R919UL

Sample Type

EDTA or Heparinized plasma

Pretreatment

None

Reportable Range

0.1 μg/mL–15 μg/mL

Calibration

With new reagent lot

Reagent Stability

Opened - until expiration date

Learn more about the V-Twin® and Viva-E® Drug Testing Systems


Enduring Expertise for Your Immunosuppressant Drug Testing Needs

With recognized drug testing expertise, Siemens Healthcare Diagnostics offers a comprehensive and expanding menu of tests across multiple instrument solutions to meet the immunosuppressant drug (ISD) testing needs of customers in any setting.

Subscription Button Icon

Keep up to date on the latest trends in healthcare. Read about current developments, new products and upcoming events.